Indoco Remedies Limited

Indoco has set its sights on the UK market, striking a deal with local distributor Clarity Pharma that the Indian firm says will allow it to launch 20 products into the UK market over the next 18 mont

C-suite remuneration across over a dozen pharma companies in India, moved upwards in 2022-23, save a few exceptions, with top-level compensation at local firms continuing to, by and large, dwarf compa

Despite a revenue rise of 4.5%, Indian pharma firm Indoco Remedies Limited started off the 2023 financial year with a rough Q1 as rising costs, lower income and a higher effective tax rate saw year-

India’s pharmaceutical companies are likely to see FY24 year-on-year growth in US market revenues slow down to 6-8% from 16% seen in FY23, based on its coverage universe of 25 companies, rating agency